A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors
Open Access
- 6 April 2001
- Vol. 91 (8) , 1543-1548
- https://doi.org/10.1002/1097-0142(20010415)91:8<1543::aid-cncr1163>3.0.co;2-n
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mitoxantrone in metastatic apudomas: a phase II study of the EORTC Gastro-Intestinal Cancer Cooperative GroupBritish Journal of Cancer, 1995
- Phase II trial of dimethyltriazenoimidazole carboxamide in patients with metastatic carcinoidCancer, 1994
- Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group ResultsJNCI Journal of the National Cancer Institute, 1993
- Metastatic Carcinoid Tumors and the Malignant Carcinoid SyndromeActa Oncologica, 1993
- Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Treatment of the carcinoid tumor and the malignant carcinoid syndrome.Journal of Clinical Oncology, 1983
- THE CLASSIFICATION OF CARCINOID TUMOURSThe Lancet, 1963
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958